Merck has a long history of working to prevent and address infectious diseases, and we are focused on exploring how mAbs can help protect against disease. To learn more about Merck’s pursuit in ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Merck & Co. has acquired Modifi Biosciences, a developer of cancer therapies that was spun out of Yale University, in a deal potentially worth more than $1 billion. Modifi on Wednesday said the ...

“Merck’s legacy spans over 33 years here in Scotland, and Livingston has quickly become the centre of excellence for diagnostic mAbs," said Jessica Copeland, head of diagnostics and regulated ...

mAbs are used by health and science professionals around the world to determine blood typing. The investment will also create an initial 10 new jobs, bringing Merck’s workforce in Scotland to ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...